Literature DB >> 16077242

Pituitary adenomas in childhood.

S K Singh1, Rohit Aggarwal.   

Abstract

Pituitary adenomas are common tumors composed of adenohypophysial cells. Although they usually arise in the sella turcica, they may occasionally be ectopic. Pituitary adenomas are rarely diagnosed in childhood and adolescence, but their mass effect and endocrine abnormalities can compromise both quality and length of life. Many signs or symptoms of pituitary adenoma, complained of in adulthood, not became evident during adolescence, suggesting true prevalence of this tumor in teenagers is higher than expected. Pititury adenoma occuring during adolescence are associated with features or therapeutic needs sometimes different from those occuring in adulthood. At the onset of disease, delay in growth was rarely observed in teenagers with pituitary adenomas. Many girls complain of oligoamenorrhoea and galactorrhoea, while headache and delay in pubertal development are the most commons features in boys. Hypopituitarism is occasionally encountered in adolescence. Early diagnosis and appropriate choice of therapy are necessary to avoid permanent endocrine complications of disease and its treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16077242     DOI: 10.1007/bf02724183

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  43 in total

1.  Brain tumors in children; clinical analysis of 164 cases.

Authors:  C H DAVIS; G L ODOM; B WOODHALL
Journal:  Pediatrics       Date:  1956-12       Impact factor: 7.124

2.  Frequent loss of the P16INK4a gene product in human pituitary tumors.

Authors:  M Woloschak; A Yu; J Xiao; K D Post
Journal:  Cancer Res       Date:  1996-06-01       Impact factor: 12.701

3.  Structure, expression, and function of human pituitary tumor-transforming gene (PTTG).

Authors:  X Zhang; G A Horwitz; T R Prezant; A Valentini; M Nakashima; M D Bronstein; S Melmed
Journal:  Mol Endocrinol       Date:  1999-01

Review 4.  Growth-hormone and prolactin excess.

Authors:  A Colao; G Lombardi
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

Review 5.  Genetic basis of endocrine disease: pituitary tumor pathogenesis.

Authors:  I Shimon; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

Review 6.  The role of hormones, growth factors and their receptors in pituitary tumorigenesis.

Authors:  S Ezzat
Journal:  Brain Pathol       Date:  2001-07       Impact factor: 6.508

7.  Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization.

Authors:  A Colao; C Di Somma; S Loche; A Di Sarno; M Klain; R Pivonello; M Pietrosante; M Salvatore; G Lombardi
Journal:  Clin Endocrinol (Oxf)       Date:  2000-03       Impact factor: 3.478

8.  Prolactinomas express human heparin-binding secretory transforming gene (hst) protein product: marker of tumour invasiveness.

Authors:  I Shimon; D R Hinton; M H Weiss; S Melmed
Journal:  Clin Endocrinol (Oxf)       Date:  1998-01       Impact factor: 3.478

Review 9.  Hyperprolactinaemia and pituitary adenomas in adolescence.

Authors:  P Dissaneevate; G L Warne
Journal:  J Pediatr Endocrinol Metab       Date:  1998 Jul-Aug       Impact factor: 1.634

10.  Pediatric pituitary adenomas.

Authors:  T Mindermann; C B Wilson
Journal:  Neurosurgery       Date:  1995-02       Impact factor: 4.654

View more
  2 in total

1.  Treatment and prognosis of pituitary adenomas in children.

Authors:  Kai Shu; Lin Han; Huaqiu Zhang; Ting Lei; Ling Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

2.  Silent Crooke's cell corticotroph adenoma of the pituitary gland presenting as delayed puberty.

Authors:  Dinesh Giri; Federico Roncaroli; Ajay Sinha; Mohammed Didi; Senthil Senniappan
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.